Concepedia

Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers

Kathleen M. Darcy, William E. Brady, John W. McBroom, Jeffrey G. Bell, Robert C. Young, William P. McGuire, R. Ilona Linnoila, Denver T. Hendricks, Tomás Bonome, John Farley

Gynecologic Oncology · 2008 · 47 citations · 40 references

DOIFull text

Open access

Concepts

References

40

Cancer Statistics, 2007

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text

, , +16

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

An immunochemical analysis of the human nuclear phosphoprotein p53

Bořivoj Vojtěšek, Jiří Bártek, Carol Midgley et al. · Journal of Immunological Methods · 1992 · 539 citations

, , +14

Overexpression and mutation of p53 in epithelial ovarian cancer.

Jeffrey R. Marks, A M Davidoff, B. J. Kerns et al. · PubMed · 1991 · 471 citations · Full text

, , +17

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

Pierre Hainaut · Nucleic Acids Research · 1998 · 453 citations · Full text

, , +16